Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene
Author:
- 1 February 2017
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 138, 57-60
Abstract
No abstract availableKeywords
Funding Information
- NIH (AI116635)
This publication has 22 references indexed in Scilit:
- PDGF Receptor-α Does Not Promote HCMV Entry into Epithelial and Endothelial Cells but Increased Quantities Stimulate Entry by an Abnormal PathwayPLOS Pathogens, 2012
- Recombinant Phenotyping of Cytomegalovirus UL54 Mutations That Emerged during Cell Passages in the Presence of either Ganciclovir or FoscarnetAntimicrobial Agents and Chemotherapy, 2011
- Phosphonoformic Acid Inhibits Viral Replication by Trapping the Closed Form of the DNA PolymeraseJournal of Biological Chemistry, 2011
- Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapyJournal of Clinical Virology, 2011
- Differentiation between Polymorphisms and Resistance-Associated Mutations in Human Cytomegalovirus DNA PolymeraseAntimicrobial Agents and Chemotherapy, 2010
- Antiviral Drug Resistance of Human CytomegalovirusClinical Microbiology Reviews, 2010
- Recombinant Phenotyping of Cytomegalovirus UL97 Kinase Sequence Variants for Ganciclovir ResistanceAntimicrobial Agents and Chemotherapy, 2010
- Three‐dimensional modeling of cytomegalovirus DNA polymerase and preliminary analysis of drug resistanceProteins: Structure, Function, and Bioinformatics, 2006
- Phenotyping of Cytomegalovirus Drug Resistance Mutations by Using Recombinant Viruses Incorporating a Reporter GeneAntimicrobial Agents and Chemotherapy, 2005
- How Evolution of Mutations Conferring Drug Resistance Affects Viral Dynamics and Clinical Outcomes of Cytomegalovirus-Infected Hematopoietic Cell Transplant RecipientsJournal of Clinical Microbiology, 2005